Back
 OJOph  Vol.2 No.1 , February 2012
Usefulness of Botulinum Toxin Type-A in the Treatment of Chronic Sixth Nerve Palsy
Abstract: Purpose: The purpose of the study was to evaluate the efficacy of botulinum toxin type A (BTX-A) injection in patients with acquired VI nerve palsy. Methods: Twenty-eight patients (16 F and 12 M), mean age 36.4 +/-- 17.8 DS; range 10 - 69 years with acquired VI nerve palsy, have been treated with BTX-A injection into the ipsilateral medial rectus, at least 6 months after onset. At 6 months follow up, a paresis and a paralysis, were respectively diagnosed if the affected eye could be actively abducted or not, across the mid-line; a simple horizontal rectus muscle procedure was performed for the paresis whilst for the paralysis, both a horizontal and vertical muscle transportation procedure were required. Results: A gradual physiological recovery of the lateral rectus muscle was observed in 9 (32%) patients (GROUP I) and surgical treatment was therefore unnecessary; the remaining 19 cases (68%), of which 5 paresis (GROUP II) and 14 paralysis (GROUP III) underwent surgery and within 1 year were all restored to orthotropia. Conclusion: Botulinum toxin type-A (BTX-A) injection is an invaluable tool in the differential diagnosis between paresis versus paralysis of the VIth nerve, allowing the correct choice of surgical procedure.
Cite this paper: L. Sabetti, I. Greco, D. Lodovico and A. Berarducci, "Usefulness of Botulinum Toxin Type-A in the Treatment of Chronic Sixth Nerve Palsy," Open Journal of Ophthalmology, Vol. 2 No. 1, 2012, pp. 1-4. doi: 10.4236/ojoph.2012.21001.
References

[1]   H. L. Hung, L. Y. Kao and M. H. Sun, “Botulinum Toxin Treatment for Acute Traumatic Complete Sixth Nerve Palsy,” Eye, Vol. 19, No. 3, 2005, pp. 337-341. doi:10.1038/sj.eye.6701460

[2]   T. Krzizok, “Botulinum Toxin Injections for the Treatment of Strabismus. Which Indications Are Still Useful Today?” Ophthalmology, Vol. 104, No. 9, 2007, pp. 759-762.

[3]   S. Gujar, J. Trobe and D. Gandhi, “Spontaneous Resolution of a Meckel’s Cave Arachnoid Cyst Causing Sixth Cranial Nerve Palsy,” Journal of Neuro-Ophthalmol, Vol. 28, No. 3, 2008, pp. 186-191. doi:10.1097/WNO.0b013e318183be6c

[4]   J. M. Holmes, D. A. Leske and S. P. Christiansen, “Initial Treatment Outcomes in Chronic Sixth Nerve Palsy,” Journal of AAPOS, Vol. 5, No. 6, 2001, pp. 370-376. doi:10.1067/mpa.2001.120176

[5]   L. Kowal, E. Wong and C. Yahalom, “Botulinum Toxin in the Treatment of Strabismus. A Review of Its Use and Effects,” Disability and Rehabilitation, Vol. 29, No. 23, 2007, pp. 1823-1831. doi:10.1080/09638280701568189

[6]   A. B. Scott, “Botulinum Toxin Injection into Extraocular Muscles as an Alternative to Strabismus Surgery,” Ophthalmology, Vol. 10, 1980, pp. 1040-1049.

[7]   P. Riordan-Eva and J. P. Lee, “Management of VIth Nerve Palsy-Avoiding Unnecessary Surgery,” Eye, Vol. 4, 1992, pp. 386-390. doi:10.1038/eye.1992.79

[8]   J. S. Elston and J. P. Lee “Paralytic Strabismus: The Role of Botulinum Toxin,” British Journal of Ophthalmology, Vol. 69, No. 12, 1985, pp. 891-896. doi:10.1136/bjo.69.12.891

[9]   G. Kommerell, D. Olivier and H. Theopold, “Adaptive Programming of Phasic and Tonic Components in Saccadic Eye Movements. Investigations of Patients with Abducens Palsy,” Investigative Ophthalmology & Visual Science, Vol. 15, No. 8, 1976, pp. 657-660.

[10]   J. L. Demer, M. C. Ortube, E. C. Engle and N. Thacker, “High-Resolution Magnetic Resonance Imaging Demonstrates Abnormalities of Motor Nerves and Extraocular Muscles in Patients with Neuropathic Strabismus,” Journal of AAPOS, Vol. 10, No. 2, 2006, pp. 135-142. doi:10.1016/j.jaapos.2005.12.006

[11]   J. Acheson, C. Bentley, J. Shallo-Hoffmann and M. Gresty, “Dissociated Effects of Botulinum Toxin Chemoden-ervation on Ocular Deviation and Saccade Dynamics in Chronic Lateral Rectus Palsy,” British Journal of Oph- thalmology, Vol.1, No. 82, 1998, pp. 67-71. doi:10.1136/bjo.82.1.67

[12]   A. G. Altintas, H. B. Arifoglu, D. Dal and S. Simsek, “Are Most Sixth Nerve Palsies Really Paralytic?” Journal of Pediatric Ophthalmology Strabismus, Vol. 48, No. 3, 2011, pp. 187-191. doi:10.3928/01913913-20100618-01

[13]   L. Kowal, E. Wong and C. Yahalom, “Botulinum Toxin in the Treatment of Strabismus. A Review of Its Use and Effects,” Disability and Rehabilitation, Vol. 29, No. 23, 2007, pp. 1823-1831. doi:10.1080/09638280701568189

[14]   R. Fitzsimons, J. P. Lee and J. Elston, “Treatment of Sixth Nerve Palsy in Adults with Combined Botulinum Toxin Chemodenervation and Surgery,” Ophthalmology, Vol. 95, No. 11, 1988, pp. 1535-1542.

[15]   J. Khan, I. Kumar and I. B. Marsh, “Botulinum Toxin Injection for Postoperative Diplopia Testing in Adult Strabismus,” Journal of American Association for Pediatric Ophthalmology and Strabismus, Vol. 12, No. 1, 2008, pp.46-48.

[16]   J. O. Lee, “Modern Management of Sixth Nerve Palsy,” Australian and New Zealand Journal of Ophthalmology, Vol. 20, No. 1, 1992, pp. 41-46.

[17]   J. Lee, S. Harris, K. Cooper, C. MacEwen and S. Jones, “Results of a Prospective Randomized Trial of Botulinum Toxin Therapy in Acute Unilateral Sixth Nerve Palsy,” Journal of Pediatric Ophthalmology Strabismus, Vol. 31, No. 5, 1994, pp. 283-286.

[18]   M. S. Sanjari, K. G. Falavarjani, M. B. Kashkouli, G. H. Aghai, M. Nojomi and H. Rostami, “Botulinum Toxin Injection with and without Electromyographic Assistance for Treatment of Abducens Nerve Palsy: A Pilot Study,” Journal of AAPOS, Vol. 12, No. 3, 2008, pp. 259-262. doi:10.1016/j.jaapos.2007.11.006

[19]   L. Y. Kao and A. N. Chao, “Subtenon Injection of Botulinum Toxin for Treatment of Traumatic Sixth Nerve Palsy,” Journal of Pediatric Ophthalmology Strabismus, Vol. 40, No. 1, 2003, pp. 27-30.

[20]   E. C. Benabent, P. García Hermosa, M. T. Arazola and J. L. Alió y Sanz, “Botulinum Toxin Injection without Electromyographic Assistance,” Journal of Pediatric Ophthalmology Strabismus, Vol. 39, No. 4, 2002, pp. 231-234.

[21]   No Authors Listed, “Botulinum Toxin Therapy of Eye Muscle Disorders. Safety and Effectiveness. American Academy of Ophthalmology,” Ophthalmology, 1989, pp. 37-41.

 
 
Top